Kim MH - Search Results

1

Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells.

Choi MJ, Jung KH, Kim D, Lee H, Zheng HM, Park BH, Hong SW, Kim MH, Hong S, Hong SS. Choi MJ, et al. Among authors: kim d, kim mh. Cancer Lett. 2011 Jul 28;306(2):190-6. doi: 10.1016/j.canlet.2011.03.005. Epub 2011 Apr 3. Cancer Lett. 2011. PMID: 21463918

2

Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer.

Yan HH, Jung KH, Son MK, Fang Z, Kim SJ, Ryu YL, Kim J, Kim MH, Hong SS. Yan HH, et al. Among authors: kim sj, kim j, kim mh. Oncotarget. 2014 Oct 15;5(19):9150-68. doi: 10.18632/oncotarget.2363. Oncotarget. 2014. PMID: 25193856 Free PMC article.

3

New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage.

Yadav DK, Rai R, Kumar N, Singh S, Misra S, Sharma P, Shaw P, Pérez-Sánchez H, Mancera RL, Choi EH, Kim MH, Pratap R. Yadav DK, et al. Among authors: kim mh. Sci Rep. 2016 Dec 6;6:38128. doi: 10.1038/srep38128. Sci Rep. 2016. PMID: 27922047 Free PMC article.

4

Novel SIRT1 inhibitor 15-deoxy-Δ12,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells.

Tae IH, Park EY, Dey P, Son JY, Lee SY, Jung JH, Saloni S, Kim MH, Kim HS. Tae IH, et al. Among authors: kim mh, kim hs. Int J Oncol. 2018 Dec;53(6):2518-2530. doi: 10.3892/ijo.2018.4561. Epub 2018 Sep 13. Int J Oncol. 2018. PMID: 30221742 Free PMC article.

5

Anti-cancer effect of GV1001 for prostate cancer: function as a ligand of GnRHR.

Kim JW, Yadav DK, Kim SJ, Lee MY, Park JM, Kim BS, Kim MH, Park HG, Kang KW. Kim JW, et al. Among authors: kim bs, kim sj, kim mh. Endocr Relat Cancer. 2019 Feb;26(2):147-162. doi: 10.1530/ERC-18-0454. Endocr Relat Cancer. 2019. PMID: 30400054

6

A Stilbenoid Isorhapontigenin as a Potential Anti-Cancer Agent against Breast Cancer through Inhibiting Sphingosine Kinases/Tubulin Stabilization.

Subedi L, Teli MK, Lee JH, Gaire BP, Kim MH, Kim SY. Subedi L, et al. Among authors: kim sy, kim mh. Cancers (Basel). 2019 Dec 5;11(12):1947. doi: 10.3390/cancers11121947. Cancers (Basel). 2019. PMID: 31817453 Free PMC article.

7

Structure tuning of pyrazolylpyrrole derivatives as ERK inhibitors utilizing dual tools; 3D-QSAR and side-chain hopping.

Kim MH, Chung JY, Ryu JS, Hah JM. Kim MH, et al. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4900-4. doi: 10.1016/j.bmcl.2011.06.016. Epub 2011 Jun 23. Bioorg Med Chem Lett. 2011. PMID: 21775139

8

3D-QSAR studies of 1,2-diaryl-1H-benzimidazole derivatives as JNK3 inhibitors with protective effects in neuronal cells.

Kim MH, Ryu JS, Hah JM. Kim MH, et al. Bioorg Med Chem Lett. 2013 Mar 15;23(6):1639-42. doi: 10.1016/j.bmcl.2013.01.082. Epub 2013 Jan 29. Bioorg Med Chem Lett. 2013. PMID: 23416008

9

PIFA-Promoted, Solvent-Controlled Selective Functionalization of C(sp²)-H or C(sp³)-H: Nitration via C-N Bond Cleavage of CH₃NO₂, Cyanation, or Oxygenation in Water.

Mudithanapelli C, Dhorma LP, Kim MH. Mudithanapelli C, et al. Among authors: kim mh. Org Lett. 2019 May 3;21(9):3098-3102. doi: 10.1021/acs.orglett.9b00751. Epub 2019 Apr 15. Org Lett. 2019. PMID: 30986072

10

Cold atmospheric plasma generated reactive species aided inhibitory effects on human melanoma cells: an in vitro and in silico study.

Yadav DK, Adhikari M, Kumar S, Ghimire B, Han I, Kim MH, Choi EH. Yadav DK, et al. Among authors: kim mh. Sci Rep. 2020 Feb 25;10(1):3396. doi: 10.1038/s41598-020-60356-0. Sci Rep. 2020. PMID: 32099012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,646 results

Search Page

Filters